Biography
Dr. Geneviève Goulet obtained her Bachelor of Science degree in Biopharmaceutical Sciences from the University of Ottawa in 2003 and completed a Bachelor of Pharmacy degree in 2006 at Laval University. After 4 years of practice in pediatric pharmacy at the Children's Hospital of Eastern Ontario (CHEO), she completed her PharmD at the University of Toronto in 2012. Back at CHEO, her clinical expertise is in pediatric hematology-oncology. Her research interests include the areas of pharmacy practice and medication use in pediatrics.
Since 2018, Dr. Goulet has served as an expert advisor to the Ontario Steering Committee for Cancer Drug Programs (OSCCD) at the Ontario Ministry of Health. Her role is to provide evidence-based clinical, health research, and health economics advice to the Executive Director of Ontario's Public Drug Programs. Composed mostly of experts in adult oncology, part of my role is to bring a pediatric perspective to this committee.
Expertise
- Pharmacotherapy
- Pharmaceutical practice
- Pediatrics
- Hematology-oncology
Research Projects
Dr. Goulet is co-investigator in a prospective study evaluating hypoglycemia during treatment of acute lymphoblastic leukemia in pediatric patients. She is also co-lead investigator in a study about the side effects of Pegaspargase use during treatment of acute lymphoblastic leukemia in pediatric patients.
- Mathies N, Laforest I, Tang K, Goulet G, Abbott LS. Evaluation of Pegaspargase adverse events among adolescents and young adults (AYAs) and younger patients with lymphoid malignancies at the Children’s Hospital of Eastern Ontario (CHEO). Poster presented at: American Society of Clinical Oncology (ASCO); June, 2018; Chicago.
- Lavenant E, Bains T, Vaillancourt R, Goulet G, Hilliard J, Pascuet E, Halton J. Evaluation of the Efficacy and Toxicity of Once Daily Gentamicin for Febrile Neutropenia in Pediatric Oncology Patients. Poster presented at: Canadian Society of Hospital Pharmacist, Professional Practice Conference; 2011; Toronto.
- Ramphal R, Bains T, Goulet G, Vaillancourt R. Occupational Exposure to Chemotherapy of Pharmacy Personnel at a Single Centre. The Canadian Journal of Hospital Pharmacy. 2015;68(2). doi:10.4212/cjhp.v68i2.1435
- Bains T, Goulet G, Hilliard J, Trottier N. Multidisciplinary Use of Oncology Pharmacy-Generated Medication Calendars. Poster presented at: Hematology Oncology Pharmacist Association (HOPA), Annual Conference; March, 2010; New Orleans.
- Goulet G, Bains T, Rocheleau C, Bellefeuille M, Ramphal R, Vaillancourt R. Environmental contamination and occupational exposure to cytotoxic drugs in an oncology pharmacy satellite. Poster presented at: National Oncology Pharmacy Symposium (NOPS); October, 2009; Ottawa.
- Fowkes C, Bains T, Goulet G, Vaillancourt R. Retrospective review of the non-oncology uses of rituximab in pediatric patients. 2009. Affiche présentée à: 18th Pediatric Pharmacy Advocacy Group Annual Conference; 2009; Baltimore.
- Arpin M, Goulet G, Goldberg F, Vaillancourt R. Évaluation du contrôle de la douleur ainsi que de la satisfaction du personnel infirmier et des mères à la suite de l’implantation d’un programme d’automédication en obstétriqu. The Canadian Journal of Hospital Pharmacy. 2007;60(1). doi:https://doi.org/10.4212/cjhp.v60i1.139
- Vaillancourt R, Goulet G, Yannick P, Dallaire S, Sorfleet C. Ordonnance de départ informatisée : un sondage rétrospectif. Canadian Journal of Hospital PharmacyCanadian Journal of Hospital PharmacyCanadian Journal of Hospital PharmacyCanadian Journal of Hospital Pharmacy. 2007;60(2). doi:doi.org/10.4212/cjhp.v60i2.153